C58 Malignant neoplasm of placenta

✓ Billable ICD-10-CM 2026
Open C58 in Web App →

The ICD-10-CM code for Malignant neoplasm of placenta is C58 (FY2026). It is a billable, claim-ready diagnosis code.

Classification

Section
C51-C58: Malignant neoplasms of female genital organs (C51-C58)
Category C58
1 code (1 billable)
FY2026 Status
Stable since FY2024

Also Known As

ICD-10-CM Alphabetic Index entries that lead to C58:

  • Choriocarcinoma › unspecified site › female
  • Carcinoma (malignant) › chorionic › unspecified site › female
Includes
  • choriocarcinoma NOS
  • chorionepithelioma NOS
Excludes1
Not coded here. These conditions should NOT be coded together with C58.
  • chorioadenoma (destruens) (D39.2)
  • hydatidiform mole NOS (O01.9)
  • invasive hydatidiform mole (D39.2)
  • male choriocarcinoma NOS (C62.9-)
  • malignant hydatidiform mole (D39.2)

U.S. Hospital Utilization

  • An estimated 440 U.S. inpatient stays in 2023 included C58 among the documented diagnoses.

Source: National Inpatient Sample (NIS), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality, 2016–2023. National survey-weighted estimates.

Official Coding Guidelines

Tx of primary site (TOC entry)

a. Admission/Encounter for treatment of primary site ............................................................. 33

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.2.a
Tx of secondary site (TOC entry)

b. Admission/Encounter for treatment of secondary site .......................................................... 33

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.2.b

Source: CMS — ICD-10-CM Official Guidelines for Coding and Reporting, FY2026

References

Search all 70,000+ ICD-10-CM codes →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2025-10-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial